aluates Reports

$ 0.0

Automative

Global CAR-NK Cell Therapy Market Research Report 2025

Published Date: April 2025

Report Code: QYRE-Auto-4Z19349

BUY CHAPTERS

Global CAR-NK Cell Therapy Market Research Report 2025

Code: QYRE-Auto-4Z19349

Report

April 2025

Pages:101

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

CAR-NK Cell Therapy Market Size

The global market for CAR-NK Cell Therapy was valued at US$ 2361 million in the year 2024 and is projected to reach a revised size of US$ 3304 million by 2031, growing at a CAGR of 5.7% during the forecast period.

CAR-NK Cell Therapy Market

CAR-NK cell therapy is an advanced cellular therapy technique that combines the natural anticancer ability of natural killer (NK) cells with the specific targeting function of chimeric antigen receptors (CARs). Through genetic engineering, CAR structures capable of recognizing specific tumor antigens are introduced into NK cells, thereby enhancing their targeting ability and killing power. This therapy has shown great potential in treating various types of cancers, including hematological tumors and solid tumors. CAR-NK cell therapy has lower toxic and side effects and better safety, making it a promising supplement or alternative to CAR-T cell therapy.

North American market for CAR-NK Cell Therapy is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for CAR-NK Cell Therapy is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for CAR-NK Cell Therapy in Solid Tumors is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of CAR-NK Cell Therapy include Artiva Biotherapeutics, Cartherics, Cytoimmune Therapeutics, Dragonfly Therapeutics, Fate Therapeutics, Glycostem Therapeutics, ImmuneBridge, ImmunityBio, Nkarta, NKGen Biotech, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for CAR-NK Cell Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CAR-NK Cell Therapy.

The CAR-NK Cell Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global CAR-NK Cell Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the CAR-NK Cell Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of CAR-NK Cell Therapy Market Report

Report Metric	Details
Report Name	CAR-NK Cell Therapy Market
Accounted market size in year	US$ 2361 million
Forecasted market size in 2031	US$ 3304 million
CAGR	5.7%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Cytokine Therapy Adoptive NK Cell Therapy Genetically Engineered NK Cell Therapy Others
Segment by Application	Solid Tumors Hematological Malignancies Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Artiva Biotherapeutics, Cartherics, Cytoimmune Therapeutics, Dragonfly Therapeutics, Fate Therapeutics, Glycostem Therapeutics, ImmuneBridge, ImmunityBio, Nkarta, NKGen Biotech, ONK Therapeutics, Senti Biosciences, Base Therapeutics, Persongen, Alpha Biopharma, Guangzhou Doublle Bioproduct, Rui Therapeutics, Allife Medicine, Morecell, Simnova, Nuwacell
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of CAR-NK Cell Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is CAR-NK Cell Therapy Market growing?

Ans: The CAR-NK Cell Therapy Market witnessing a CAGR of 5.7% during the forecast period 2025-2031.

What is the CAR-NK Cell Therapy Market size in 2031?

Ans: The CAR-NK Cell Therapy Market size in 2031 will be US$ 3304 million.

Who are the main players in the CAR-NK Cell Therapy Market report?

Ans: The main players in the CAR-NK Cell Therapy Market are Artiva Biotherapeutics, Cartherics, Cytoimmune Therapeutics, Dragonfly Therapeutics, Fate Therapeutics, Glycostem Therapeutics, ImmuneBridge, ImmunityBio, Nkarta, NKGen Biotech, ONK Therapeutics, Senti Biosciences, Base Therapeutics, Persongen, Alpha Biopharma, Guangzhou Doublle Bioproduct, Rui Therapeutics, Allife Medicine, Morecell, Simnova, Nuwacell

What are the Application segmentation covered in the CAR-NK Cell Therapy Market report?

Ans: The Applications covered in the CAR-NK Cell Therapy Market report are Solid Tumors, Hematological Malignancies, Others

What are the Type segmentation covered in the CAR-NK Cell Therapy Market report?

Ans: The Types covered in the CAR-NK Cell Therapy Market report are Cytokine Therapy, Adoptive NK Cell Therapy, Genetically Engineered NK Cell Therapy, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global CAR-NK Cell Therapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Cytokine Therapy

1.2.3 Adoptive NK Cell Therapy

1.2.4 Genetically Engineered NK Cell Therapy

1.2.5 Others

1.3 Market by Application

1.3.1 Global CAR-NK Cell Therapy Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Solid Tumors

1.3.3 Hematological Malignancies

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global CAR-NK Cell Therapy Market Perspective (2020-2031)

2.2 Global CAR-NK Cell Therapy Growth Trends by Region

2.2.1 Global CAR-NK Cell Therapy Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 CAR-NK Cell Therapy Historic Market Size by Region (2020-2025)

2.2.3 CAR-NK Cell Therapy Forecasted Market Size by Region (2026-2031)

2.3 CAR-NK Cell Therapy Market Dynamics

2.3.1 CAR-NK Cell Therapy Industry Trends

2.3.2 CAR-NK Cell Therapy Market Drivers

2.3.3 CAR-NK Cell Therapy Market Challenges

2.3.4 CAR-NK Cell Therapy Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top CAR-NK Cell Therapy Players by Revenue

3.1.1 Global Top CAR-NK Cell Therapy Players by Revenue (2020-2025)

3.1.2 Global CAR-NK Cell Therapy Revenue Market Share by Players (2020-2025)

3.2 Global Top CAR-NK Cell Therapy Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by CAR-NK Cell Therapy Revenue

3.4 Global CAR-NK Cell Therapy Market Concentration Ratio

3.4.1 Global CAR-NK Cell Therapy Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by CAR-NK Cell Therapy Revenue in 2024

3.5 Global Key Players of CAR-NK Cell Therapy Head office and Area Served

3.6 Global Key Players of CAR-NK Cell Therapy, Product and Application

3.7 Global Key Players of CAR-NK Cell Therapy, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 CAR-NK Cell Therapy Breakdown Data by Type

4.1 Global CAR-NK Cell Therapy Historic Market Size by Type (2020-2025)

4.2 Global CAR-NK Cell Therapy Forecasted Market Size by Type (2026-2031)

5 CAR-NK Cell Therapy Breakdown Data by Application

5.1 Global CAR-NK Cell Therapy Historic Market Size by Application (2020-2025)

5.2 Global CAR-NK Cell Therapy Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America CAR-NK Cell Therapy Market Size (2020-2031)

6.2 North America CAR-NK Cell Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America CAR-NK Cell Therapy Market Size by Country (2020-2025)

6.4 North America CAR-NK Cell Therapy Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe CAR-NK Cell Therapy Market Size (2020-2031)

7.2 Europe CAR-NK Cell Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe CAR-NK Cell Therapy Market Size by Country (2020-2025)

7.4 Europe CAR-NK Cell Therapy Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific CAR-NK Cell Therapy Market Size (2020-2031)

8.2 Asia-Pacific CAR-NK Cell Therapy Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific CAR-NK Cell Therapy Market Size by Region (2020-2025)

8.4 Asia-Pacific CAR-NK Cell Therapy Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America CAR-NK Cell Therapy Market Size (2020-2031)

9.2 Latin America CAR-NK Cell Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America CAR-NK Cell Therapy Market Size by Country (2020-2025)

9.4 Latin America CAR-NK Cell Therapy Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa CAR-NK Cell Therapy Market Size (2020-2031)

10.2 Middle East & Africa CAR-NK Cell Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa CAR-NK Cell Therapy Market Size by Country (2020-2025)

10.4 Middle East & Africa CAR-NK Cell Therapy Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Artiva Biotherapeutics

11.1.1 Artiva Biotherapeutics Company Details

11.1.2 Artiva Biotherapeutics Business Overview

11.1.3 Artiva Biotherapeutics CAR-NK Cell Therapy Introduction

11.1.4 Artiva Biotherapeutics Revenue in CAR-NK Cell Therapy Business (2020-2025)

11.1.5 Artiva Biotherapeutics Recent Development

11.2 Cartherics

11.2.1 Cartherics Company Details

11.2.2 Cartherics Business Overview

11.2.3 Cartherics CAR-NK Cell Therapy Introduction

11.2.4 Cartherics Revenue in CAR-NK Cell Therapy Business (2020-2025)

11.2.5 Cartherics Recent Development

11.3 Cytoimmune Therapeutics

11.3.1 Cytoimmune Therapeutics Company Details

11.3.2 Cytoimmune Therapeutics Business Overview

11.3.3 Cytoimmune Therapeutics CAR-NK Cell Therapy Introduction

11.3.4 Cytoimmune Therapeutics Revenue in CAR-NK Cell Therapy Business (2020-2025)

11.3.5 Cytoimmune Therapeutics Recent Development

11.4 Dragonfly Therapeutics

11.4.1 Dragonfly Therapeutics Company Details

11.4.2 Dragonfly Therapeutics Business Overview

11.4.3 Dragonfly Therapeutics CAR-NK Cell Therapy Introduction

11.4.4 Dragonfly Therapeutics Revenue in CAR-NK Cell Therapy Business (2020-2025)

11.4.5 Dragonfly Therapeutics Recent Development

11.5 Fate Therapeutics

11.5.1 Fate Therapeutics Company Details

11.5.2 Fate Therapeutics Business Overview

11.5.3 Fate Therapeutics CAR-NK Cell Therapy Introduction

11.5.4 Fate Therapeutics Revenue in CAR-NK Cell Therapy Business (2020-2025)

11.5.5 Fate Therapeutics Recent Development

11.6 Glycostem Therapeutics

11.6.1 Glycostem Therapeutics Company Details

11.6.2 Glycostem Therapeutics Business Overview

11.6.3 Glycostem Therapeutics CAR-NK Cell Therapy Introduction

11.6.4 Glycostem Therapeutics Revenue in CAR-NK Cell Therapy Business (2020-2025)

11.6.5 Glycostem Therapeutics Recent Development

11.7 ImmuneBridge

11.7.1 ImmuneBridge Company Details

11.7.2 ImmuneBridge Business Overview

11.7.3 ImmuneBridge CAR-NK Cell Therapy Introduction

11.7.4 ImmuneBridge Revenue in CAR-NK Cell Therapy Business (2020-2025)

11.7.5 ImmuneBridge Recent Development

11.8 ImmunityBio

11.8.1 ImmunityBio Company Details

11.8.2 ImmunityBio Business Overview

11.8.3 ImmunityBio CAR-NK Cell Therapy Introduction

11.8.4 ImmunityBio Revenue in CAR-NK Cell Therapy Business (2020-2025)

11.8.5 ImmunityBio Recent Development

11.9 Nkarta

11.9.1 Nkarta Company Details

11.9.2 Nkarta Business Overview

11.9.3 Nkarta CAR-NK Cell Therapy Introduction

11.9.4 Nkarta Revenue in CAR-NK Cell Therapy Business (2020-2025)

11.9.5 Nkarta Recent Development

11.10 NKGen Biotech

11.10.1 NKGen Biotech Company Details

11.10.2 NKGen Biotech Business Overview

11.10.3 NKGen Biotech CAR-NK Cell Therapy Introduction

11.10.4 NKGen Biotech Revenue in CAR-NK Cell Therapy Business (2020-2025)

11.10.5 NKGen Biotech Recent Development

11.11 ONK Therapeutics

11.11.1 ONK Therapeutics Company Details

11.11.2 ONK Therapeutics Business Overview

11.11.3 ONK Therapeutics CAR-NK Cell Therapy Introduction

11.11.4 ONK Therapeutics Revenue in CAR-NK Cell Therapy Business (2020-2025)

11.11.5 ONK Therapeutics Recent Development

11.12 Senti Biosciences

11.12.1 Senti Biosciences Company Details

11.12.2 Senti Biosciences Business Overview

11.12.3 Senti Biosciences CAR-NK Cell Therapy Introduction

11.12.4 Senti Biosciences Revenue in CAR-NK Cell Therapy Business (2020-2025)

11.12.5 Senti Biosciences Recent Development

11.13 Base Therapeutics

11.13.1 Base Therapeutics Company Details

11.13.2 Base Therapeutics Business Overview

11.13.3 Base Therapeutics CAR-NK Cell Therapy Introduction

11.13.4 Base Therapeutics Revenue in CAR-NK Cell Therapy Business (2020-2025)

11.13.5 Base Therapeutics Recent Development

11.14 Persongen

11.14.1 Persongen Company Details

11.14.2 Persongen Business Overview

11.14.3 Persongen CAR-NK Cell Therapy Introduction

11.14.4 Persongen Revenue in CAR-NK Cell Therapy Business (2020-2025)

11.14.5 Persongen Recent Development

11.15 Alpha Biopharma

11.15.1 Alpha Biopharma Company Details

11.15.2 Alpha Biopharma Business Overview

11.15.3 Alpha Biopharma CAR-NK Cell Therapy Introduction

11.15.4 Alpha Biopharma Revenue in CAR-NK Cell Therapy Business (2020-2025)

11.15.5 Alpha Biopharma Recent Development

11.16 Guangzhou Doublle Bioproduct

11.16.1 Guangzhou Doublle Bioproduct Company Details

11.16.2 Guangzhou Doublle Bioproduct Business Overview

11.16.3 Guangzhou Doublle Bioproduct CAR-NK Cell Therapy Introduction

11.16.4 Guangzhou Doublle Bioproduct Revenue in CAR-NK Cell Therapy Business (2020-2025)

11.16.5 Guangzhou Doublle Bioproduct Recent Development

11.17 Rui Therapeutics

11.17.1 Rui Therapeutics Company Details

11.17.2 Rui Therapeutics Business Overview

11.17.3 Rui Therapeutics CAR-NK Cell Therapy Introduction

11.17.4 Rui Therapeutics Revenue in CAR-NK Cell Therapy Business (2020-2025)

11.17.5 Rui Therapeutics Recent Development

11.18 Allife Medicine

11.18.1 Allife Medicine Company Details

11.18.2 Allife Medicine Business Overview

11.18.3 Allife Medicine CAR-NK Cell Therapy Introduction

11.18.4 Allife Medicine Revenue in CAR-NK Cell Therapy Business (2020-2025)

11.18.5 Allife Medicine Recent Development

11.19 Morecell

11.19.1 Morecell Company Details

11.19.2 Morecell Business Overview

11.19.3 Morecell CAR-NK Cell Therapy Introduction

11.19.4 Morecell Revenue in CAR-NK Cell Therapy Business (2020-2025)

11.19.5 Morecell Recent Development

11.20 Simnova

11.20.1 Simnova Company Details

11.20.2 Simnova Business Overview

11.20.3 Simnova CAR-NK Cell Therapy Introduction

11.20.4 Simnova Revenue in CAR-NK Cell Therapy Business (2020-2025)

11.20.5 Simnova Recent Development

11.21 Nuwacell

11.21.1 Nuwacell Company Details

11.21.2 Nuwacell Business Overview

11.21.3 Nuwacell CAR-NK Cell Therapy Introduction

11.21.4 Nuwacell Revenue in CAR-NK Cell Therapy Business (2020-2025)

11.21.5 Nuwacell Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

List of Tables

Table 1. Global CAR-NK Cell Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Cytokine Therapy

Table 3. Key Players of Adoptive NK Cell Therapy

Table 4. Key Players of Genetically Engineered NK Cell Therapy

Table 5. Key Players of Others

Table 6. Global CAR-NK Cell Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global CAR-NK Cell Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global CAR-NK Cell Therapy Market Size by Region (2020-2025) & (US$ Million)

Table 9. Global CAR-NK Cell Therapy Market Share by Region (2020-2025)

Table 10. Global CAR-NK Cell Therapy Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 11. Global CAR-NK Cell Therapy Market Share by Region (2026-2031)

Table 12. CAR-NK Cell Therapy Market Trends

Table 13. CAR-NK Cell Therapy Market Drivers

Table 14. CAR-NK Cell Therapy Market Challenges

Table 15. CAR-NK Cell Therapy Market Restraints

Table 16. Global CAR-NK Cell Therapy Revenue by Players (2020-2025) & (US$ Million)

Table 17. Global CAR-NK Cell Therapy Market Share by Players (2020-2025)

Table 18. Global Top CAR-NK Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CAR-NK Cell Therapy as of 2024)

Table 19. Ranking of Global Top CAR-NK Cell Therapy Companies by Revenue (US$ Million) in 2024

Table 20. Global 5 Largest Players Market Share by CAR-NK Cell Therapy Revenue (CR5 and HHI) & (2020-2025)

Table 21. Global Key Players of CAR-NK Cell Therapy, Headquarters and Area Served

Table 22. Global Key Players of CAR-NK Cell Therapy, Product and Application

Table 23. Global Key Players of CAR-NK Cell Therapy, Date of Enter into This Industry

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global CAR-NK Cell Therapy Market Size by Type (2020-2025) & (US$ Million)

Table 26. Global CAR-NK Cell Therapy Revenue Market Share by Type (2020-2025)

Table 27. Global CAR-NK Cell Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 28. Global CAR-NK Cell Therapy Revenue Market Share by Type (2026-2031)

Table 29. Global CAR-NK Cell Therapy Market Size by Application (2020-2025) & (US$ Million)

Table 30. Global CAR-NK Cell Therapy Revenue Market Share by Application (2020-2025)

Table 31. Global CAR-NK Cell Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 32. Global CAR-NK Cell Therapy Revenue Market Share by Application (2026-2031)

Table 33. North America CAR-NK Cell Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 34. North America CAR-NK Cell Therapy Market Size by Country (2020-2025) & (US$ Million)

Table 35. North America CAR-NK Cell Therapy Market Size by Country (2026-2031) & (US$ Million)

Table 36. Europe CAR-NK Cell Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. Europe CAR-NK Cell Therapy Market Size by Country (2020-2025) & (US$ Million)

Table 38. Europe CAR-NK Cell Therapy Market Size by Country (2026-2031) & (US$ Million)

Table 39. Asia-Pacific CAR-NK Cell Therapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 40. Asia-Pacific CAR-NK Cell Therapy Market Size by Region (2020-2025) & (US$ Million)

Table 41. Asia-Pacific CAR-NK Cell Therapy Market Size by Region (2026-2031) & (US$ Million)

Table 42. Latin America CAR-NK Cell Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 43. Latin America CAR-NK Cell Therapy Market Size by Country (2020-2025) & (US$ Million)

Table 44. Latin America CAR-NK Cell Therapy Market Size by Country (2026-2031) & (US$ Million)

Table 45. Middle East & Africa CAR-NK Cell Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Middle East & Africa CAR-NK Cell Therapy Market Size by Country (2020-2025) & (US$ Million)

Table 47. Middle East & Africa CAR-NK Cell Therapy Market Size by Country (2026-2031) & (US$ Million)

Table 48. Artiva Biotherapeutics Company Details

Table 49. Artiva Biotherapeutics Business Overview

Table 50. Artiva Biotherapeutics CAR-NK Cell Therapy Product

Table 51. Artiva Biotherapeutics Revenue in CAR-NK Cell Therapy Business (2020-2025) & (US$ Million)

Table 52. Artiva Biotherapeutics Recent Development

Table 53. Cartherics Company Details

Table 54. Cartherics Business Overview

Table 55. Cartherics CAR-NK Cell Therapy Product

Table 56. Cartherics Revenue in CAR-NK Cell Therapy Business (2020-2025) & (US$ Million)

Table 57. Cartherics Recent Development

Table 58. Cytoimmune Therapeutics Company Details

Table 59. Cytoimmune Therapeutics Business Overview

Table 60. Cytoimmune Therapeutics CAR-NK Cell Therapy Product

Table 61. Cytoimmune Therapeutics Revenue in CAR-NK Cell Therapy Business (2020-2025) & (US$ Million)

Table 62. Cytoimmune Therapeutics Recent Development

Table 63. Dragonfly Therapeutics Company Details

Table 64. Dragonfly Therapeutics Business Overview

Table 65. Dragonfly Therapeutics CAR-NK Cell Therapy Product

Table 66. Dragonfly Therapeutics Revenue in CAR-NK Cell Therapy Business (2020-2025) & (US$ Million)

Table 67. Dragonfly Therapeutics Recent Development

Table 68. Fate Therapeutics Company Details

Table 69. Fate Therapeutics Business Overview

Table 70. Fate Therapeutics CAR-NK Cell Therapy Product

Table 71. Fate Therapeutics Revenue in CAR-NK Cell Therapy Business (2020-2025) & (US$ Million)

Table 72. Fate Therapeutics Recent Development

Table 73. Glycostem Therapeutics Company Details

Table 74. Glycostem Therapeutics Business Overview

Table 75. Glycostem Therapeutics CAR-NK Cell Therapy Product

Table 76. Glycostem Therapeutics Revenue in CAR-NK Cell Therapy Business (2020-2025) & (US$ Million)

Table 77. Glycostem Therapeutics Recent Development

Table 78. ImmuneBridge Company Details

Table 79. ImmuneBridge Business Overview

Table 80. ImmuneBridge CAR-NK Cell Therapy Product

Table 81. ImmuneBridge Revenue in CAR-NK Cell Therapy Business (2020-2025) & (US$ Million)

Table 82. ImmuneBridge Recent Development

Table 83. ImmunityBio Company Details

Table 84. ImmunityBio Business Overview

Table 85. ImmunityBio CAR-NK Cell Therapy Product

Table 86. ImmunityBio Revenue in CAR-NK Cell Therapy Business (2020-2025) & (US$ Million)

Table 87. ImmunityBio Recent Development

Table 88. Nkarta Company Details

Table 89. Nkarta Business Overview

Table 90. Nkarta CAR-NK Cell Therapy Product

Table 91. Nkarta Revenue in CAR-NK Cell Therapy Business (2020-2025) & (US$ Million)

Table 92. Nkarta Recent Development

Table 93. NKGen Biotech Company Details

Table 94. NKGen Biotech Business Overview

Table 95. NKGen Biotech CAR-NK Cell Therapy Product

Table 96. NKGen Biotech Revenue in CAR-NK Cell Therapy Business (2020-2025) & (US$ Million)

Table 97. NKGen Biotech Recent Development

Table 98. ONK Therapeutics Company Details

Table 99. ONK Therapeutics Business Overview

Table 100. ONK Therapeutics CAR-NK Cell Therapy Product

Table 101. ONK Therapeutics Revenue in CAR-NK Cell Therapy Business (2020-2025) & (US$ Million)

Table 102. ONK Therapeutics Recent Development

Table 103. Senti Biosciences Company Details

Table 104. Senti Biosciences Business Overview

Table 105. Senti Biosciences CAR-NK Cell Therapy Product

Table 106. Senti Biosciences Revenue in CAR-NK Cell Therapy Business (2020-2025) & (US$ Million)

Table 107. Senti Biosciences Recent Development

Table 108. Base Therapeutics Company Details

Table 109. Base Therapeutics Business Overview

Table 110. Base Therapeutics CAR-NK Cell Therapy Product

Table 111. Base Therapeutics Revenue in CAR-NK Cell Therapy Business (2020-2025) & (US$ Million)

Table 112. Base Therapeutics Recent Development

Table 113. Persongen Company Details

Table 114. Persongen Business Overview

Table 115. Persongen CAR-NK Cell Therapy Product

Table 116. Persongen Revenue in CAR-NK Cell Therapy Business (2020-2025) & (US$ Million)

Table 117. Persongen Recent Development

Table 118. Alpha Biopharma Company Details

Table 119. Alpha Biopharma Business Overview

Table 120. Alpha Biopharma CAR-NK Cell Therapy Product

Table 121. Alpha Biopharma Revenue in CAR-NK Cell Therapy Business (2020-2025) & (US$ Million)

Table 122. Alpha Biopharma Recent Development

Table 123. Guangzhou Doublle Bioproduct Company Details

Table 124. Guangzhou Doublle Bioproduct Business Overview

Table 125. Guangzhou Doublle Bioproduct CAR-NK Cell Therapy Product

Table 126. Guangzhou Doublle Bioproduct Revenue in CAR-NK Cell Therapy Business (2020-2025) & (US$ Million)

Table 127. Guangzhou Doublle Bioproduct Recent Development

Table 128. Rui Therapeutics Company Details

Table 129. Rui Therapeutics Business Overview

Table 130. Rui Therapeutics CAR-NK Cell Therapy Product

Table 131. Rui Therapeutics Revenue in CAR-NK Cell Therapy Business (2020-2025) & (US$ Million)

Table 132. Rui Therapeutics Recent Development

Table 133. Allife Medicine Company Details

Table 134. Allife Medicine Business Overview

Table 135. Allife Medicine CAR-NK Cell Therapy Product

Table 136. Allife Medicine Revenue in CAR-NK Cell Therapy Business (2020-2025) & (US$ Million)

Table 137. Allife Medicine Recent Development

Table 138. Morecell Company Details

Table 139. Morecell Business Overview

Table 140. Morecell CAR-NK Cell Therapy Product

Table 141. Morecell Revenue in CAR-NK Cell Therapy Business (2020-2025) & (US$ Million)

Table 142. Morecell Recent Development

Table 143. Simnova Company Details

Table 144. Simnova Business Overview

Table 145. Simnova CAR-NK Cell Therapy Product

Table 146. Simnova Revenue in CAR-NK Cell Therapy Business (2020-2025) & (US$ Million)

Table 147. Simnova Recent Development

Table 148. Nuwacell Company Details

Table 149. Nuwacell Business Overview

Table 150. Nuwacell CAR-NK Cell Therapy Product

Table 151. Nuwacell Revenue in CAR-NK Cell Therapy Business (2020-2025) & (US$ Million)

Table 152. Nuwacell Recent Development

Table 153. Research Programs/Design for This Report

Table 154. Key Data Information from Secondary Sources

Table 155. Key Data Information from Primary Sources

Table 156. Authors List of This Report

List of Figures

Figure 1. CAR-NK Cell Therapy Picture

Figure 2. Global CAR-NK Cell Therapy Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global CAR-NK Cell Therapy Market Share by Type: 2024 VS 2031

Figure 4. Cytokine Therapy Features

Figure 5. Adoptive NK Cell Therapy Features

Figure 6. Genetically Engineered NK Cell Therapy Features

Figure 7. Others Features

Figure 8. Global CAR-NK Cell Therapy Market Size by Application (2020-2031) & (US$ Million)

Figure 9. Global CAR-NK Cell Therapy Market Share by Application: 2024 VS 2031

Figure 10. Solid Tumors Case Studies

Figure 11. Hematological Malignancies Case Studies

Figure 12. Others Case Studies

Figure 13. CAR-NK Cell Therapy Report Years Considered

Figure 14. Global CAR-NK Cell Therapy Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 15. Global CAR-NK Cell Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 16. Global CAR-NK Cell Therapy Market Share by Region: 2024 VS 2031

Figure 17. Global CAR-NK Cell Therapy Market Share by Players in 2024

Figure 18. Global CAR-NK Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 19. The Top 10 and 5 Players Market Share by CAR-NK Cell Therapy Revenue in 2024

Figure 20. North America CAR-NK Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. North America CAR-NK Cell Therapy Market Share by Country (2020-2031)

Figure 22. United States CAR-NK Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Canada CAR-NK Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe CAR-NK Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe CAR-NK Cell Therapy Market Share by Country (2020-2031)

Figure 26. Germany CAR-NK Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. France CAR-NK Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. U.K. CAR-NK Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Italy CAR-NK Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Russia CAR-NK Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Nordic Countries CAR-NK Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific CAR-NK Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific CAR-NK Cell Therapy Market Share by Region (2020-2031)

Figure 34. China CAR-NK Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Japan CAR-NK Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. South Korea CAR-NK Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Southeast Asia CAR-NK Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. India CAR-NK Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Australia CAR-NK Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America CAR-NK Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America CAR-NK Cell Therapy Market Share by Country (2020-2031)

Figure 42. Mexico CAR-NK Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Brazil CAR-NK Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa CAR-NK Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa CAR-NK Cell Therapy Market Share by Country (2020-2031)

Figure 46. Turkey CAR-NK Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Saudi Arabia CAR-NK Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. UAE CAR-NK Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Artiva Biotherapeutics Revenue Growth Rate in CAR-NK Cell Therapy Business (2020-2025)

Figure 50. Cartherics Revenue Growth Rate in CAR-NK Cell Therapy Business (2020-2025)

Figure 51. Cytoimmune Therapeutics Revenue Growth Rate in CAR-NK Cell Therapy Business (2020-2025)

Figure 52. Dragonfly Therapeutics Revenue Growth Rate in CAR-NK Cell Therapy Business (2020-2025)

Figure 53. Fate Therapeutics Revenue Growth Rate in CAR-NK Cell Therapy Business (2020-2025)

Figure 54. Glycostem Therapeutics Revenue Growth Rate in CAR-NK Cell Therapy Business (2020-2025)

Figure 55. ImmuneBridge Revenue Growth Rate in CAR-NK Cell Therapy Business (2020-2025)

Figure 56. ImmunityBio Revenue Growth Rate in CAR-NK Cell Therapy Business (2020-2025)

Figure 57. Nkarta Revenue Growth Rate in CAR-NK Cell Therapy Business (2020-2025)

Figure 58. NKGen Biotech Revenue Growth Rate in CAR-NK Cell Therapy Business (2020-2025)

Figure 59. ONK Therapeutics Revenue Growth Rate in CAR-NK Cell Therapy Business (2020-2025)

Figure 60. Senti Biosciences Revenue Growth Rate in CAR-NK Cell Therapy Business (2020-2025)

Figure 61. Base Therapeutics Revenue Growth Rate in CAR-NK Cell Therapy Business (2020-2025)

Figure 62. Persongen Revenue Growth Rate in CAR-NK Cell Therapy Business (2020-2025)

Figure 63. Alpha Biopharma Revenue Growth Rate in CAR-NK Cell Therapy Business (2020-2025)

Figure 64. Guangzhou Doublle Bioproduct Revenue Growth Rate in CAR-NK Cell Therapy Business (2020-2025)

Figure 65. Rui Therapeutics Revenue Growth Rate in CAR-NK Cell Therapy Business (2020-2025)

Figure 66. Allife Medicine Revenue Growth Rate in CAR-NK Cell Therapy Business (2020-2025)

Figure 67. Morecell Revenue Growth Rate in CAR-NK Cell Therapy Business (2020-2025)

Figure 68. Simnova Revenue Growth Rate in CAR-NK Cell Therapy Business (2020-2025)

Figure 69. Nuwacell Revenue Growth Rate in CAR-NK Cell Therapy Business (2020-2025)

Figure 70. Bottom-up and Top-down Approaches for This Report

Figure 71. Data Triangulation

Figure 72. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global CAR T Cell Therapy Market Research Report 2025

Global CAR M Cell Therapy Market Research Report 2025

Global CAR T Therapy for Hematological Cancer Market Research Report 2024

Global CAR T Cell Service Market Research Report 2024

Global CAR T cell Therapy Drug Market Research Report 2025

Global Autologous CAR T Cell Therapy Market Research Report 2024

Global CAR T Cell Development Service Market Research Report 2024

CAR T Cell Based Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Drug based on CAR T Cell Market Research Report 2025

CAR T Cellular Immunotherapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global CAR T Cell Therapy Agents Market Research Report 2025

Global Drugs Based on CAR T cell Market Research Report 2025

Global CAR T Cell Immunotherapy Market Insights Forecast to 2030

Global CAR NK Cell Development Service Market Research Report 2025

Global CAR T Therapy For B Cell Malignancies Market Research Report 2025

Global Multi Target CAR T Cell Therapy Market Research Report 2025

Cancer Drug based on CAR T Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Natural Killer NK Cell Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global CD19 targeted CAR T Cell Therapy Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-2O19977

Thu Sep 18 00:00:00 UTC 2025

Add to Cart

Global Intelligent Elderly Care Equipment Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-3E8132

Wed Sep 17 00:00:00 UTC 2025

Add to Cart

Global Radiation Monitoring Systems Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-23I7304

Tue Sep 16 00:00:00 UTC 2025

Add to Cart

Global Ophthalmology Homeopathic Products Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-8T5982

Tue Sep 16 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global CAR-NK Cell Therapy Market Research Report 2025

Published Date: April 2025

Report Code: QYRE-Auto-4Z19349

Global CAR-NK Cell Therapy Market Research Report 2025

FEATURED COMPANIES

CAR-NK Cell Therapy Market Size

CAR-NK Cell Therapy Market

Scope of CAR-NK Cell Therapy Market Report

Chapter Outline

FAQ for this report

How fast is CAR-NK Cell Therapy Market growing?

What is the CAR-NK Cell Therapy Market size in 2031?

Who are the main players in the CAR-NK Cell Therapy Market report?

What are the Application segmentation covered in the CAR-NK Cell Therapy Market report?

What are the Type segmentation covered in the CAR-NK Cell Therapy Market report?

FEATURED COMPANIES

RELATED REPORTS